Yes. Someone may be able to continue buprenorphine or methadone during residential rehab when the medication remains clinically appropriate and the program can coordinate it safely. Evidence-based guidance does not support automatically stopping medication for opioid use disorder simply because a person enters a residential treatment setting.

Why might continuing MOUD during residential rehab matter?

Buprenorphine and methadone are FDA-approved treatments for opioid use disorder. Continuing an effective medication can help prevent withdrawal, reduce cravings, and support treatment retention. Unplanned discontinuation can destabilize someone who has already been doing well on medication.

Does every residential rehab allow methadone or buprenorphine?

No. Programs vary in staffing, medication policies, licensing, storage procedures, and coordination with outside prescribers or opioid treatment programs. A residential facility may administer medication on site, coordinate dosing with an outside provider, or be unable to support a particular medication.

That is why the current policy should be confirmed before admission rather than assumed.

How is methadone continuity different from buprenorphine continuity?

Methadone used for opioid use disorder is generally dispensed through a SAMHSA-certified opioid treatment program, so residential care may require coordination with that OTP. Buprenorphine can be prescribed in a wider range of medical settings, which can make continuity logistically different.

Should someone stop MOUD before entering rehab?

Not without medical guidance. Abruptly stopping methadone or buprenorphine can cause opioid withdrawal and may increase the risk of return to use. The prescribing clinician and residential program should coordinate a plan whenever possible.

What should admissions know before arrival?

Provide the exact medication name, dose, prescribing or dispensing provider, pharmacy or OTP contact information, and the time of the most recent dose. This information can support medication reconciliation at admission and help prevent missed or duplicated doses.

Can a residential program require someone to switch medications?

A program should not make medication decisions solely for convenience. Changes should be based on clinical assessment and applicable prescribing or regulatory requirements. If a facility cannot support an existing medication, that should be discussed before admission so another appropriate arrangement can be considered.

Can MOUD continue after residential treatment?

Yes. Methadone or buprenorphine may continue after discharge for as long as clinically appropriate. The discharge plan should clarify who will prescribe or dispense the medication and when follow-up care will occur.

Trinity Behavioral Health provides information about adult residential addiction treatment. This article does not state that Trinity currently provides or continues methadone or buprenorphine; current medication capabilities should be verified directly before admission.

Frequently asked questions

Can a person on methadone enter residential rehab?

Potentially, yes. The program must be able to coordinate the medication safely and in compliance with applicable rules.

Can a person on buprenorphine enter residential rehab?

Potentially, yes. Continuing buprenorphine can be clinically appropriate when it is part of the patient’s OUD treatment plan.

Does residential rehab require tapering off MOUD?

Not as a universal evidence-based rule. Any taper should be individualized and medically supervised.

What if the residential program cannot continue the medication?

Ask whether it can coordinate with an outside prescriber or OTP, or whether another program can meet the person’s treatment and medication needs more appropriately.

Sources

This article is general educational information and does not replace individualized medical advice.

Can Someone Continue Buprenorphine or Methadone During Residential Rehab?